what happens when people stop taking glp 1 who Glucagon-like peptide-1 (GLP-1) drugs after using them for some time regain, on average, roughly 60 percent of the weight they had lost within a year. However, the pace New research is taking a
Description
The SURMOUNT-5 trial, published in 2025 in the New England Journal of Medicine, directly compared tirzepatide with semaglutide
Ongoing trial extensions and postmarketing data continue to clarify the durability of outcomes

Laura: Deliver the dose by pressing the injection button in all the way

These lesions were not located solely within the epithelia

After rapid weight loss, the loads are lighter, but the movement pattern is still heavy. Clients often: Stay in a wide, externally rotated stance Over-grip with toes Roll onto the outside or inside edges of the feet in old, familiar ways Knees & hips Obesity research shows: Greater and more variable knee joint loads and altered gait patterns in people with obesity compared to normal-weight controls
